FORM 8.3 - AON PLC - Amendment

FORM 8.3 - AON PLC - Amendment

BARCLAYS PLC

 

FORM 8.3 - Amendment to purchase & sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 05 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

470,316

0.21%

1,765,878

0.78%

 

(2)

Derivatives (other than options):

95,497

0.04%

13,691

0.01%

 

(3)

Options and agreements to
purchase/sell:

24,200

0.01%

24,200

0.01%

 
TOTAL:

590,013

0.26%

1,803,769

0.80%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

1

233.4300 USD

Purchase

1

233.5700 USD

Purchase

1

233.6000 USD

Purchase

3

233.5933 USD

Purchase

3

233.1900 USD

Purchase

5

233.5850 USD

Purchase

15

232.6600 USD

Purchase

26

233.4457 USD

Purchase

27

233.2000 USD

Purchase

43

233.8600 USD

Purchase

52

233.4923 USD

Purchase

100

233.7300 USD

Purchase

100

233.9600 USD

Purchase

144

233.6397 USD

Purchase

146

232.9854 USD

Purchase

198

233.3100 USD

Purchase

200

233.3000 USD

Purchase

200

232.8600 USD

Purchase

249

233.5776 USD

Purchase

278

233.0242 USD

Purchase

295

232.9457 USD

Purchase

520

232.9986 USD

Purchase

527

233.2514 USD

Purchase

699

233.6752 USD

Purchase

711

233.2401 USD

Purchase

860

233.9795 USD

Purchase

1,052

233.2337 USD

Purchase

1,062

233.1157 USD

Purchase

1,504

234.0233 USD

Purchase

1,522

233.0756 USD

Purchase

2,010

232.8624 USD

Purchase

7,064

233.0939 USD

Purchase

7,706

233.3845 USD

Purchase

8,227

233.3725 USD

Purchase

8,759

233.8123 USD

Purchase

9,549

233.2050 USD

Purchase

10,954

233.2166 USD

Purchase

18,819

233.9800 USD

Sale

1

233.4800 USD

Sale

1

233.4900 USD

Sale

1

233.5800 USD

Sale

2

233.5500 USD

Sale

2

233.5550 USD

Sale

4

232.3500 USD

Sale

11

233.0300 USD

Sale

16

232.7081 USD

Sale

24

233.3400 USD

Sale

38

233.3700 USD

Sale

40

233.1113 USD

Sale

46

232.3450 USD

Sale

52

233.4923 USD

Sale

100

233.2800 USD

Sale

108

233.4878 USD

Sale

111

233.2452 USD

Sale

111

233.2912 USD

Sale

193

233.3800 USD

Sale

200

233.3300 USD

Sale

203

233.3349 USD

Sale

300

233.3866 USD

Sale

384

233.4730 USD

Sale

600

233.1116 USD

Sale

607

233.2539 USD

Sale

870

233.9750 USD

Sale

1,325

233.3705 USD

Sale

1,510

233.4892 USD

Sale

3,002

233.3267 USD

Sale

3,210

233.1929 USD

Sale

5,477

233.2166 USD

Sale

5,718

233.3872 USD

Sale

5,918

233.0420 USD

Sale

7,517

233.3757 USD

Sale

8,707

233.9274 USD

Sale

17,755

233.9800 USD

Sale

18,427

233.1583 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

7 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-1,200

220.0000

American

Jul 16, 2021

Call Options

Purchased

1,200

240.0000

American

Jul 16, 2021

Call Options

Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings